AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 156 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $742,500 | -12.6% | 30,000 | 0.0% | 0.00% | -33.3% |
Q2 2023 | $849,600 | +23.3% | 30,000 | 0.0% | 0.00% | +50.0% |
Q1 2023 | $689,100 | -18.2% | 30,000 | 0.0% | 0.00% | -33.3% |
Q4 2022 | $842,400 | -0.7% | 30,000 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $848,000 | +45.7% | 30,000 | +50.0% | 0.00% | +200.0% |
Q1 2022 | $582,000 | – | 20,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rock Springs Capital Management LP | 2,710,061 | $67,074,010 | 1.80% |
Bellevue Group AG | 4,013,500 | $99,334,125 | 1.60% |
Eagle Health Investments LP | 267,630 | $6,623,843 | 1.46% |
ARMISTICE CAPITAL, LLC | 3,324,000 | $82,269,000 | 1.26% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 454,000 | $11,236,500 | 0.61% |
Frazier Life Sciences Management, L.P. | 292,002 | $7,227,050 | 0.48% |
ArrowMark Colorado Holdings LLC | 1,573,359 | $38,940,635 | 0.47% |
Deep Track Capital, LP | 422,247 | $10,450,613 | 0.40% |
FARALLON CAPITAL MANAGEMENT LLC | 2,750,829 | $68,083,018 | 0.34% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 24,000 | $593,520 | 0.20% |